Articles by bwarman

Location is key: Understanding RNA localisation in cancer

4th October 2021

Dr Faraz Mardakheh has received a project grant from the Medical Research Council, part of UK Research and Innovation, to investigate how RNA localisation becomes dysregulated during cancer progression.

Read more

Mapping the emergence of treatment resistance in leukaemia

28th September 2021

Research led by Barts Cancer Institute, Queen Mary University of London, has identified a new role for a group of cells called adipocytes in contributing to treatment resistance in a type of leukaemia. Published in Nature Communications, the findings broaden the understanding of resistance pathways in blood cancer cells, which is critical for developing novel treatment strategies to improve outcomes for people with leukaemia.

Read more

Tackling blood cancer with Blood Cancer UK

10th September 2021

This Blood Cancer Awareness Month, find out about the Blood Cancer UK-funded research projects currently underway at the Barts Cancer Institute, which span from looking at the specific genetic changes that drive blood cancer development, to identifying new treatment strategies to improve the outcomes for patients.

Read more

BCI researcher receives UKRI Future Leaders Fellowship Award

9th September 2021

Dr Benjamin Werner from Barts Cancer Institute, Queen Mary University of London, is one of the next generation of UK science leaders to receive funding through UK Research and Innovation’s (UKRI) Future Leaders Fellowships scheme. Dr Werner will receive an award of approximately £1.4 million, which will support a research project looking at the evolutionary dynamics of circular extra-chromosomal DNA (ecDNA) in human cancers.

Read more

Combining medicine with blood cancer research

3rd September 2021

This Blood Cancer Awareness Month, we spoke with Dr John Riches, Clinical Senior Lecturer at Barts Cancer Institute (BCI), Queen Mary University of London. Dr Riches is a clinician scientist who splits his time between BCI where he leads a group researching blood cancer in our Centre for Haemato-Oncology and directs the MSc Cancer & Clinical Oncology Programme, and St Bartholemew’s Hospital where he treats blood cancer patients.

Read more

Miguel Ganuza receives ASH Global Research Award

24th August 2021

Congratulations to Dr Miguel Ganuza from Barts Cancer Institute, Queen Mary University of London, who has been selected by the American Society of Hematology (ASH) to receive the 2021 ASH Global Research Award. Dr Ganuza is one of twelve talented early-career investigators selected for this award.

Read more

Search News